Case Report: Safety and efficacy of blinatumomab in combination with donor lymphocyte infusion for the prophylaxis of relapse following allogeneic hematopoietic stem cell transplantation in a pediatric patient with acute lymphoblastic leukemia - Top-Institutions - MDSpire

Case Report: Safety and efficacy of blinatumomab in combination with donor lymphocyte infusion for the prophylaxis of relapse following allogeneic hematopoietic stem cell transplantation in a pediatric patient with acute lymphoblastic leukemia

By
Yi-Tong Li
Yu Li
Li-Na Wang
Li-Bin Huang
June 17, 2026
0 min

Frontiers In Immunology

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

Children’s Oncology Group

Philadelphia, PA
Key Differentiators
- Pediatric Oncology
- Hematology
#2

Seattle Children’s Hospital

Seattle, WA
Key Differentiators
- Pediatric Hematology
- Oncology
#3

University of Washington

Seattle, WA
Key Differentiators
- Hematology
- Oncology
#4

The University of Texas MD Anderson Cancer Center

Houston, TX
Key Differentiators
- Hematology
- Oncology

Original Source(s)

Frontiers In Immunology

Case Report: Safety and efficacy of blinatumomab in combination with donor lymphocyte infusion for the prophylaxis of relapse following allogeneic hematopoietic stem cell transplantation in a pediatric patient with acute lymphoblastic leukemia

by Yi-Tong Li, Yu Li, Li-Na Wang, Li-Bin Huang
June 17, 2026

Related Content

Frontiers In Medicine

ABO gene polymorphisms: a molecular bridge linking disease susceptibility to therapeutic outcomes

Frontiers In Medicine

Pembrolizumab-associated immune-related hepatitis: a retrospective case report analysis

by Ke-qian Chen, Yang Chen, Jing-Fu Peng, Yi Huang, Xiang Liu
June 17, 2026

Frontiers In Immunology

Conversion-oriented multimodal therapy enabling definitive surgery in a patient with FIGO stage IVA cervical cancer at high risk of fistula formation: a case report

by Yanling Yuan, Wanming He, Lihua Tong, Yu Yang, Wen Yang
June 17, 2026